Covista Inc. filings document current reports on operating results, academic performance, investor communications and strategic progress for its healthcare education portfolio. Recent Form 8-K records furnish quarterly results releases, enrollment metrics, revenue and earnings measures, fiscal guidance, share repurchase activity, debt refinancing references and institutional updates for Chamberlain and Walden.
The company's Regulation FD disclosures also include investor newsletters describing milestones, partnerships, workforce-related initiatives and operational progress. Covista's filing record identifies public-company disclosure themes tied to results of operations, capital allocation, governance signatories, cautionary forward-looking statements and the company's current identity as a NYSE-listed healthcare educator.
Covista Inc. reported third-quarter 2026 results with revenue of $487.0 million, higher than the prior-year period. Income from continuing operations was $58.0 million, while a loss in discontinued operations reduced net income to $41.6 million.
For the first nine months of fiscal 2026, Covista generated revenue of $1.45 billion and net income of $179.8 million. Operating cash flow was strong at $346.5 million, supporting $238.2 million of share repurchases and significant debt refinancing activity.
The company replaced its remaining 5.50% Senior Secured Notes with a new $510.0 million Term Loan B maturing in 2033, and maintained compliance with all credit facility covenants. Deferred revenue rose, reflecting future educational services already billed to students.
Covista Inc. reported third-quarter 2026 results with revenue of $487.0 million, higher than the prior-year period. Income from continuing operations was $58.0 million, while a loss in discontinued operations reduced net income to $41.6 million.
For the first nine months of fiscal 2026, Covista generated revenue of $1.45 billion and net income of $179.8 million. Operating cash flow was strong at $346.5 million, supporting $238.2 million of share repurchases and significant debt refinancing activity.
The company replaced its remaining 5.50% Senior Secured Notes with a new $510.0 million Term Loan B maturing in 2033, and maintained compliance with all credit facility covenants. Deferred revenue rose, reflecting future educational services already billed to students.
Covista Inc. reported third quarter fiscal 2026 results showing steady growth and stronger guidance. Revenue for the quarter was $487.0 million, up 4.5% year over year, with operating income edging up to $91.3 million. Net income from continuing operations was $58.0 million, while a loss from discontinued operations reduced total net income to $41.6 million.
Total students surpassed 100,000, with enrollment up 6.8% year over year and growth in every segment. Chamberlain revenue rose 2.3% with slightly higher operating income, Walden revenue grew 4.6% but with lower operating income, and Medical and Veterinary revenue increased 8.9% with operating income up 18.7%.
For the full fiscal year 2026, Covista raised its revenue outlook to $1,930–$1,945 million, or about 8–9% growth, and lifted adjusted earnings per share guidance to $7.95–$8.15, or roughly 19–22% growth year over year. Adjusted EBITDA for the quarter was $127.9 million, and net leverage stood at 0.7x, supported by strong cash generation and reduced long-term debt.
Covista Inc. reported third quarter fiscal 2026 results showing steady growth and stronger guidance. Revenue for the quarter was $487.0 million, up 4.5% year over year, with operating income edging up to $91.3 million. Net income from continuing operations was $58.0 million, while a loss from discontinued operations reduced total net income to $41.6 million.
Total students surpassed 100,000, with enrollment up 6.8% year over year and growth in every segment. Chamberlain revenue rose 2.3% with slightly higher operating income, Walden revenue grew 4.6% but with lower operating income, and Medical and Veterinary revenue increased 8.9% with operating income up 18.7%.
For the full fiscal year 2026, Covista raised its revenue outlook to $1,930–$1,945 million, or about 8–9% growth, and lifted adjusted earnings per share guidance to $7.95–$8.15, or roughly 19–22% growth year over year. Adjusted EBITDA for the quarter was $127.9 million, and net leverage stood at 0.7x, supported by strong cash generation and reduced long-term debt.
Covista Inc reports a 13G filing showing FMR LLC beneficially owns 2,654,243.58 shares, or 7.7% of common stock, as of 03/31/2026. The filing lists sole dispositive power for 2,654,243.58 shares and identifies Abigail P. Johnson as having shared dispositive authority. The signature dates are 05/05/2026.
Covista Inc reports a 13G filing showing FMR LLC beneficially owns 2,654,243.58 shares, or 7.7% of common stock, as of 03/31/2026. The filing lists sole dispositive power for 2,654,243.58 shares and identifies Abigail P. Johnson as having shared dispositive authority. The signature dates are 05/05/2026.
Covista Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 1,751,336 shares of Common Stock, representing 5.07% of the class as of 03/31/2026. The filer reports sole dispositive power over 1,751,336 shares and sole voting power over 260,800 shares. The filing states the ownership reflects holdings across Vanguard Capital Management LLC and certain affiliates and includes shares held by managed funds and client accounts. The filing was signed on 04/29/2026.
Covista Inc Schedule 13G: Vanguard Capital Management reports beneficial ownership of 1,751,336 shares of Common Stock, representing 5.07% of the class as of 03/31/2026. The filer reports sole dispositive power over 1,751,336 shares and sole voting power over 260,800 shares. The filing states the ownership reflects holdings across Vanguard Capital Management LLC and certain affiliates and includes shares held by managed funds and client accounts. The filing was signed on 04/29/2026.
Covista Inc reports that Vanguard Portfolio Management holds 2,451,249 shares of Common Stock, representing 7.1% of the class. The filing shows Vanguard has sole dispositive power over 2,451,249 shares and sole voting power over 29,643 shares. The disclosure identifies the reporting chain of Vanguard Portfolio Management LLC and affiliated voting/dispositive arrangements.
Covista Inc reports that Vanguard Portfolio Management holds 2,451,249 shares of Common Stock, representing 7.1% of the class. The filing shows Vanguard has sole dispositive power over 2,451,249 shares and sole voting power over 29,643 shares. The disclosure identifies the reporting chain of Vanguard Portfolio Management LLC and affiliated voting/dispositive arrangements.
Covista Inc. executive Liles Scott, President, Medical and Vet, used company shares to cover taxes on vested equity. On April 15, 2026, 448 shares of Common Stock were withheld at $112.49 per share to satisfy tax obligations tied to previously awarded restricted stock units. After this non-market, tax-withholding disposition, Scott directly holds 13,103 shares of Covista common stock.
Covista Inc. executive Liles Scott, President, Medical and Vet, used company shares to cover taxes on vested equity. On April 15, 2026, 448 shares of Common Stock were withheld at $112.49 per share to satisfy tax obligations tied to previously awarded restricted stock units. After this non-market, tax-withholding disposition, Scott directly holds 13,103 shares of Covista common stock.
Dimensional Fund Advisors LP reports ownership of 1,773,564 shares of Covista Inc common stock, representing 5.1% of the class as of 03/31/2026. The filing states the shares are owned by Dimensional-managed funds and that Dimensional disclaims beneficial ownership; Sole voting power is reported as 1,730,764 and sole dispositive power as 1,773,564.
Dimensional Fund Advisors LP reports ownership of 1,773,564 shares of Covista Inc common stock, representing 5.1% of the class as of 03/31/2026. The filing states the shares are owned by Dimensional-managed funds and that Dimensional disclaims beneficial ownership; Sole voting power is reported as 1,730,764 and sole dispositive power as 1,773,564.
Covista Inc. furnished an investor newsletter dated April 9, 2026, providing updates on key milestones, strategic developments, and operational progress. The newsletter is attached as Exhibit 99.1 and is incorporated by reference for informational purposes.
The company emphasizes that the newsletter and related information under Regulation FD are furnished, not filed, so they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other securities law filings. Covista also includes standard cautionary language that the newsletter contains forward-looking statements subject to risks described in its most recent Form 10-K and other SEC filings.
Covista Inc. furnished an investor newsletter dated April 9, 2026, providing updates on key milestones, strategic developments, and operational progress. The newsletter is attached as Exhibit 99.1 and is incorporated by reference for informational purposes.
The company emphasizes that the newsletter and related information under Regulation FD are furnished, not filed, so they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other securities law filings. Covista also includes standard cautionary language that the newsletter contains forward-looking statements subject to risks described in its most recent Form 10-K and other SEC filings.
Covista Inc ownership disclosure: The Vanguard Group amended its Schedule 13G to report 0% beneficial ownership of Covista Inc common stock, with 0 shares beneficially owned. The filing describes an internal realignment of Vanguard and disaggregation of certain subsidiaries' holdings January 12, 2026.
The amendment is signed by Vanguard's Head of Global Fund Administration on 03/26/2026 and states that Vanguard and its managed accounts have the right to receive dividends or sale proceeds for reported positions; no other person holds more than 5%.
Covista Inc ownership disclosure: The Vanguard Group amended its Schedule 13G to report 0% beneficial ownership of Covista Inc common stock, with 0 shares beneficially owned. The filing describes an internal realignment of Vanguard and disaggregation of certain subsidiaries' holdings January 12, 2026.
The amendment is signed by Vanguard's Head of Global Fund Administration on 03/26/2026 and states that Vanguard and its managed accounts have the right to receive dividends or sale proceeds for reported positions; no other person holds more than 5%.
Covista Inc. lead independent director Michael W. Malafronte reported open-market purchases of a total of 36,036 shares of Covista common stock. The trades were executed on March 10 and 11 at weighted average prices around $100.9 per share.
One purchase of 11,841 shares on March 10 was held directly, leaving 113,205 directly held shares after that trade. Two additional purchases of 15,305 and 8,890 shares were made for the Michael W Malafronte 2016 Gift Trust, an irrevocable trust for which he serves as trustee, bringing that trust’s reported holdings to 25,395 shares after the March 11 transaction.
Covista Inc. lead independent director Michael W. Malafronte reported open-market purchases of a total of 36,036 shares of Covista common stock. The trades were executed on March 10 and 11 at weighted average prices around $100.9 per share.
One purchase of 11,841 shares on March 10 was held directly, leaving 113,205 directly held shares after that trade. Two additional purchases of 15,305 and 8,890 shares were made for the Michael W Malafronte 2016 Gift Trust, an irrevocable trust for which he serves as trustee, bringing that trust’s reported holdings to 25,395 shares after the March 11 transaction.